Opus Genetics, Inc.
Phentolamine Ophthalmic Solution 0.75%
presbyopia
Countdown
103days
FDA decision · Oct 17, 2026
What's at stake
The FDA's approval decision on Phentolamine Ophthalmic Solution 0.75% for presbyopia is due Oct 17, 2026. A green light opens the market; a complete response letter (CRL) usually sinks the stock.
Primary source
· SEC 8-K
verified 13h ago
“FDA PDUFA date in October 2026 for Phentolamine Ophthalmic Solution 0.75% for the treatment of presbyopia”